ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in Los Angeles, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pancreatic Cancer
Non-Small-Cell Lung Carcinoma
Colorectal Cancer
Stomach Cancer
Esophageal Cancer
Cancer
Prostatic Cancer

Adenocarcinoma trials near Los Angeles, CA, USA:

Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma

pembrolizumab in subjects with advanced gastric and gastroesophageal adenocarcinoma. These are subjects who have progressed, or not tolerate...

Active, not recruiting
Gastric Adenocarcinoma
GastroEsophageal Cancer
Drug: Pembrolizumab
Drug: Cabozantinib

Phase 2

University of California Irvine (UCI)
University of California Irvine (UCI)

Orange, California, United States

and efficacy of relacorilant in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic adenocarcinoma...

Enrolling
Adenocarcinoma
Carcinoma, Pancreatic Ductal
Drug: Gemcitabine 1000 mg/m^2
Drug: Relacorilant 150 mg once daily (QD)

Phase 2

Corcept Therapeutics
Corcept Therapeutics

Los Angeles, California, United States and 3 other locations

with chemotherapy and chemoradiation in locally advanced esophageal adenocarcinoma to examine the safety and efficacy of the combination of ...

Active, not recruiting
Esophageal Adenocarcinoma
Drug: Carboplatin
Drug: Pembrolizumab

Phase 2

Weill Cornell Medicine (WCM)
Weill Cornell Medicine (WCM)

Los Angeles, California, United States and 3 other locations

with neoadjuvant chemotherapy for the treatment of treatment-naïve subjects with borderline resectable and locally advanced pancreatic ductal adenocarcinoma...

Enrolling
Locally Advanced Pancreatic Adenocarcinoma
Borderline Resectable Pancreatic Adenocarcinoma
Drug: PTM-101

Phase 1

PanTher Therapeutics

Newport Beach, California, United States of America and 5 other locations

(TPC) in participants with advanced/metastatic gastroesophageal adenocarcinoma. The primary hypothesis of this study is sacituzumab tirumote...

Active, not recruiting
Gastroesophageal Cancer
Drug: Supportive care measures
Biological: Sacituzumab tirumotecan

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Los Angeles, California, United States and 167 other locations

The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma...

Enrolling
Advanced Adenocarcinoma
Drug: BA3182

Phase 1

BioAtla

Los Angeles, California, United States and 8 other locations

(CLDN18.2)-positive, human epidermal growth factor receptor 2 (HER2)-negative, gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma...

Enrolling
Gastroesophageal Junction Adenocarcinoma
Esophageal Cancer
Drug: Sonesitatug vedotin
Drug: Nivolumab

Phase 3

AstraZeneca
AstraZeneca

Duarte, California, United States and 229 other locations

participants to treat locally advanced unresectable or metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma (mGEA).T...

Enrolling
Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma
Esophageal Adenocarcinoma
Drug: Budigalimab
Drug: Oxaliplatin

Phase 2

AbbVie
AbbVie

Santa Monica, California, United States and 46 other locations

The goal of this clinical trial is to learn if drug DZ-002 works to treat adults with metastatic pancreatic adenocarcinoma. It will also lea...

Invitation-only
Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer
Drug: DZ-002 - 5 mg/kg, 6 mg/kg, or 7 mg/kg

Phase 2

Hoag Health Network

Newport Beach, California, United States of America

determining the efficacy of adjuvant trifluridine and tipiracil (TAS-102) in combination with irinotecan in patients with ctDNA positive colon adenocarcinoma...

Enrolling
Colon Adenocarcinoma
Colorectal Cancer
Diagnostic Test: Signatera MRD ctDNA Assay
Combination Product: Standard Treatment

Phase 1

University of California Irvine (UCI)
University of California Irvine (UCI)

Orange, California, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems